First 2016 Cadillac CT6 Sells for $200,000 in Palm Beach
On Friday evening, the first retail production model 2016 Cadillac CT6 was successfully auctioned off at the 13th Annual Barrett-Jackson Palm Beach Auction to the tune of $200,000.
The winning bidder, dealer David Flynn of Columbiana, Ohio, can not only lay claim to being the owner of the first of Cadillac’s new flagship sedan, but he can also proudly proclaim that the entirety of his bid will benefit the Barbara Ann Karmanos Cancer Institute.
The Karmanos Cancer Institute is one of 41 National Cancer Institute-designated comprehensive cancer centers in America, and the full weight of the $200,000 donated by Flynn will directly support the expansion of the Karmanos Intensive Care Unit and the development of a 24-hour Acute Care Clinic.
“General Motors has a long history of giving back to the communities in which we live and work,” said GM Senior Vice President of Global Public Policy Bob Ferguson. “We are thrilled to continue that tradition by donating our time, funds and assets to support the Karmanos Cancer Institute’s world renowned patient care and research.”
Ferguson and his wife, Debra, will also chair the Annual Dinner on Saturday, April 25th at the GM Design Dome in Warren, Michigan. Earlier in 2015, GM Foundation donated $500,000 to support Karmanos’ cancer research efforts; in 2014, the foundation donated another $400,000. In kind, the Karmanos Cancer Institute named one of the floors in its laboratory the GM Foundation Cancer Research Floor.
“We are extremely grateful for our long-standing partnership with GM and the GM Foundation whose philanthropic contributions continue to support our mission to do all we can to end cancer,” said Gerold Bepler, M.D., Ph.D., president and CEO, Barbara Ann Karmanos Cancer Institute. “GM is constantly perfecting and advancing its vehicle engineering, as shown in the exciting Cadillac CT6. So too is our team of expert oncologists and researchers relentless in their commitment to advance discoveries that can lead to new treatments for those battling cancer.
“Together, our two Detroit-based institutions’ innovations are improving lives for the better, right here in our hometown and across the globe.”